Orismilast for Moderate-To-Severe Atopic Dermatitis: the Potential Therapeutic Value of a New Oral Pharmacological Alternative
AuthID
P-018-9PZ
P-018-9PZ
© 2025 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service